News
A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...
Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results